Immune checkpoint inhibitor administration during pregnancy: a case series

BACKGROUND: Immune checkpoint inhibitors have been widely implemented in current clinical practice. Although cancer occurs in ∼1 out of 1000 pregnancies, treatment remains challenging. Until now, limited data exist regarding immunotherapy administration during pregnancy. This systemic review aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrikopoulou, A., Korakiti, A.M., Apostolidou, K., Dimopoulos, M.A., Zagouri, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426195/
https://www.ncbi.nlm.nih.gov/pubmed/34487972
http://dx.doi.org/10.1016/j.esmoop.2021.100262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426195/
https://www.ncbi.nlm.nih.gov/pubmed/34487972
http://dx.doi.org/10.1016/j.esmoop.2021.100262

Ejemplares similares